Pyrrolidinone anilines as progesterone receptor modulators
申请人:GlaxoSmithKline LLC
公开号:US07816395B2
公开(公告)日:2010-10-19
The present invention relates to a compound represented by the following formula:
or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.
PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS
申请人:WASHBURN David G.
公开号:US20080039517A1
公开(公告)日:2008-02-14
The present invention relates to a compound represented by the following formula:
or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R
1
, R
2
, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.